Eiko Ueda, Tetsuya Fujikawa, Yoshiyuki Toya, Tadashi Kuji, Midori Kakimoto-Shino, Yuki Kawai, Tomoyuki Kawano, Kengo Azushima, Hiromichi Wakui, Kouichi Tamura. Clinical significance of a novel reticulocyte-based erythropoietin resistance index in HD patients: A retrospective study. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 2021
Yuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, Tetsuya Fujikawa, Eiko Ueda, Kengo Azushima, Sho Kinguchi, Hiroshi Mitsuhashi, Tomoyuki Kawano, Tadashi Kuji, et al. Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients. Journal of pharmacological sciences. 2021. 147. 1. 118-125
Yuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, Tetsuya Fujikawa, Eiko Ueda, Kengo Azushima, Hiroshi Mitsuhashi, Tomoyuki Kawano, Tadashi Kuji, Satoshi Yamaguchi, et al. Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial. Journal of clinical hypertension (Greenwich, Conn.). 2021. 23. 4. 870-878
